SGLT-2 inhibitors: Astra's Farxiga, Jardiance Lilly and Boehringer, Invokana J & J

Recomendado pelo AMICOR Reginaldo Hollanda Albuquerque (Brasília), com o comentário de que não sabe se é verdade mas vale a pena observar.

Newer Class of Type 2 Diabetes Medications May Reduce Risk of Death, Hospitalization For Heart Failure

Reuters reported that research suggests SGLT-2 inhibitors, “a newer class of type 2 diabetes” medications, “significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease.” The findings were presented at the American College of Cardiology meeting.